共 29 条
[1]
[Anonymous], CEREBROVASCULAR D S2
[2]
INCREASED SERUM LEVELS OF FIBRINOGEN DEGRADATION PRODUCTS DUE TO TREATMENT WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION ARE RELATED TO BLEEDING COMPLICATIONS, BUT NOT TO CORONARY PATENCY
[J].
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,
1989, 14 (03)
:581-588
[5]
Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1999, 282 (21)
:2019-2026
[7]
DECLERCK P, 1987, THROMB HAEMOSTASIS, V58, P231